title: Anti-carcinoembryonic antigen immunity.
authors.affiliation: Aventis Pasteur, Toronto, Ontario, Canada.
authors.forename: Mark
authors.initials: M
authors.lastname: DeBenedette
authors.forename: Laszlo
authors.initials: L
authors.lastname: Radvanyi
authors.forename: Devender
authors.initials: D
authors.lastname: Singh-Sandhu
authors.forename: Neil L
authors.initials: NL
authors.lastname: Berinstein
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology*; D019496:Cancer Vaccines / Q000627:therapeutic use; D002272:Carcinoembryonic Antigen / Q000276:immunology*; D004195:Disease Models, Animal; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D007167:Immunotherapy / Q000379:methods; D016219:Immunotherapy, Adoptive; D009369:Neoplasms / Q000276:immunology*
chemical_list: D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D002272:Carcinoembryonic Antigen